STOCK TITAN

Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will participate in the BofA Securities 2024 Global Health Care Conference on May 15, 2024, in Las Vegas. The fireside chat will be held at 10:00 a.m. PT / 1:00 p.m. ET / 6:00 p.m. IST. An audio webcast will be available via the Investors section of the Jazz Pharmaceuticals website.

Jazz Pharmaceuticals plc is a global biopharma company focused on developing life-changing medicines for serious diseases. The company has a diverse portfolio of treatments for sleep disorders, epilepsy, and cancer. Jazz Pharmaceuticals is headquartered in Dublin, Ireland, with a commitment to serving patients worldwide.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) parteciperà alla Conferenza Globale sulla Salute di BofA Securities 2024 il 15 maggio 2024 a Las Vegas. Il dialogo informale avrà luogo alle 10:00 AM PT / 1:00 PM ET / 6:00 PM IST. Sarà possibile seguire via webcast audio attraverso la sezione Investitori del sito web di Jazz Pharmaceuticals. Jazz Pharmaceuticals plc è una compagnia biomedica globale focalizzata nello sviluppo di farmaci rivoluzionari per malattie gravi. La compagnia presenta un portafoglio variegato di trattamenti per disturbi del sonno, epilessia e cancro. Con sede centrale a Dublino, Irlanda, si impegna a servire pazienti in tutto il mondo.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) participará en la Conferencia Global de Salud de BofA Securities 2024 el 15 de mayo de 2024 en Las Vegas. El chat informal se llevará a cabo a las 10:00 a.m. PT / 1:00 p.m. ET / 6:00 p.m. IST. Un webcast de audio estará disponible a través de la sección de Inversores en el sitio web de Jazz Pharmaceuticals. Jazz Pharmaceuticals plc es una empresa biofarmacéutica global que se centra en desarrollar medicamentos transformadores para enfermedades graves. La empresa tiene un portafolio diversificado de tratamientos para trastornos del sueño, epilepsia y cáncer. Con sede en Dublín, Irlanda, Jazz Pharmaceuticals se compromete a atender a pacientes de todo el mundo.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ)가 2024년 5월 15일 라스베이거스에서 열리는 BofA Securities 2024 글로벌 헬스케어 컨퍼런스에 참여할 예정입니다. 이 자리에서 진행될 화자와의 대화는 태평양 표준시 오전 10시 / 동부 표준시 오후 1시 / 인도 표준시 오후 6시에 열립니다. Jazz Pharmaceuticals 웹사이트의 투자자 섹션을 통해 오디오 웹캐스트를 시청할 수 있습니다. Jazz Pharmaceuticals plc는 중대한 질병에 대한 혁신적인 치료제 개발에 집중하는 글로벌 바이오제약 회사입니다. 회사는 수면 장애, 간질 및 암 치료제를 포함한 다양한 제품군을 보유하고 있으며, 아일랜드 더블린에 본사를 두고 전 세계 환자들에게 서비스를 제공하고 있습니다.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) participera à la Conférence mondiale sur la santé de BofA Securities 2024 le 15 mai 2024 à Las Vegas. La discussion informelle aura lieu à 10h00 PT / 13h00 ET / 18h00 IST. Un webcast audio sera disponible via la section Investisseurs du site web de Jazz Pharmaceuticals. Jazz Pharmaceuticals plc est une entreprise biopharmaceutique mondiale axée sur le développement de médicaments révolutionnaires pour les maladies graves. L'entreprise dispose d'un portefeuille diversifié de traitements pour les troubles du sommeil, l'épilepsie et le cancer. Basée à Dublin, en Irlande, Jazz Pharmaceuticals s'engage à servir les patients du monde entier.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) wird am 15. Mai 2024 an der BofA Securities Global Healthcare Konferenz in Las Vegas teilnehmen. Das Kamingespräch findet um 10:00 Uhr PT / 1:00 Uhr ET / 18:00 Uhr IST statt. Ein Audio-Webcast wird über den Investorenbereich der Website von Jazz Pharmaceuticals verfügbar sein. Jazz Pharmaceuticals plc ist ein weltweit tätiges Biopharmazieunternehmen, das sich auf die Entwicklung lebensverändernder Medikamente für schwere Krankheiten konzentriert. Das Unternehmen verfügt über ein diversifiziertes Portfolio an Behandlungen für Schlafstörungen, Epilepsie und Krebs. Jazz Pharmaceuticals hat seinen Hauptsitz in Dublin, Irland, und ist der Versorgung von Patienten weltweit verpflichtet.
Positive
  • None.
Negative
  • None.

DUBLIN, May 1, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the BofA Securities 2024 Global Health Care Conference on Wednesday, May 15, 2024, in Las Vegas. The fireside chat will be held at 10:00 a.m. PT / 1:00 p.m. ET / 6:00 p.m. IST.  

An audio webcast of the fireside chat will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcast will be archived on the website for 30 days.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.

Contacts:

Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717

Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948

Jazz Pharmaceuticals Logo (PRNewsFoto/Jazz Pharmaceuticals plc) (PRNewsFoto/Jazz Pharmaceuticals plc)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-the-bofa-securities-2024-health-care-conference-302132364.html

SOURCE Jazz Pharmaceuticals plc

FAQ

When will Jazz Pharmaceuticals participate in the BofA Securities 2024 Global Health Care Conference?

Jazz Pharmaceuticals will participate in the conference on Wednesday, May 15, 2024.

Where will the fireside chat be held?

The fireside chat will be held in Las Vegas.

What time will the fireside chat take place?

The fireside chat will be held at 10:00 a.m. PT / 1:00 p.m. ET / 6:00 p.m. IST.

Where can the audio webcast be accessed?

The audio webcast will be available via the Investors section of the Jazz Pharmaceuticals website.

What is Jazz Pharmaceuticals' focus as a company?

Jazz Pharmaceuticals is focused on developing life-changing medicines for serious diseases.

Where is Jazz Pharmaceuticals headquartered?

Jazz Pharmaceuticals is headquartered in Dublin, Ireland.

Jazz Pharmaceuticals, Inc.

NASDAQ:JAZZ

JAZZ Rankings

JAZZ Latest News

JAZZ Stock Data

7.65B
58.63M
2.94%
98.78%
5.94%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
DUBLIN